Efficacy and Safety of Nicorandil in Preventing Contrast-Induced Nephropathy after Elective Percutaneous Coronary Intervention: A Pooled Analysis of 1229 Patients

<div>Comparison of nicorandil versus control group for the incidence of (a) contrast-induced nephropathy (CIN) and (b) major adverse events. Abbreviations: IV, inverse variance method; CI, confidence interval.</div>

Journal of Interventional Cardiology

fig2

Figure 2

Figure 2: Efficacy and Safety of Nicorandil in Preventing Contrast-Induced Nephropathy after Elective Percutaneous Coronary Intervention: A Pooled Analysis of 1229 Patients 

Figure 2 | Efficacy and Safety of Nicorandil in Preventing Contrast-Induced Nephropathy after Elective Percutaneous Coronary Intervention: A Pooled Analysis of 1229 Patients 